Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Hyperliquid Strategies Inc | 41,671 | reported | 09 Feb 2026 | tx 2+41,671 |
| Oncobiologics, Inc. | 15,000 | reported | 26 Oct 2017 | tx 2+26,500 |
| Chanticleer Holdings, Inc. | 0 | reported | 02 Dec 2025 | tx 10+59,800−4,537 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | GRANT_AWARD | Hyperliquid Strategies Inc | 40,789 | 0.00 USD | |
| 02 Dec 2025 | OTHER | Hyperliquid Strategies Inc | 882 | — | |
| 02 Dec 2025 | OTHER | Chanticleer Holdings, Inc. | 4,537 | — | |
| 11 Jul 2023 | GRANT_AWARD | Chanticleer Holdings, Inc. | 4,000 | — | |
| 11 Dec 2023 | GRANT_AWARD | Chanticleer Holdings, Inc. | 373 | — | |
| 30 May 2023 | PURCHASE | Chanticleer Holdings, Inc. | 23,255 | 0.47 USD | first after silence |
| 14 Dec 2022 | GRANT_AWARD | Chanticleer Holdings, Inc. | 3,770 | — | |
| 15 Dec 2021 | GRANT_AWARD | Chanticleer Holdings, Inc. | 14,152 | — | |
| 02 Jul 2020 | GRANT_AWARD | Chanticleer Holdings, Inc. | 8,005 | 0.00 USD | |
| 11 Jun 2020 | PURCHASE | Chanticleer Holdings, Inc. | 2,409 | 4.01 USD | first after silence |
| 01 Apr 2020 | GRANT_AWARD | Chanticleer Holdings, Inc. | 2,557 | — | |
| 01 Apr 2020 | GRANT_AWARD | Chanticleer Holdings, Inc. | 1,279 | — | deriv |
| 26 Oct 2017 | GRANT_AWARD | Oncobiologics, Inc. | 15,000 | 0.00 USD | deriv |
| 22 Dec 2016 | PURCHASE | Oncobiologics, Inc. | 11,500 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 30 May 2023.